MedTrace Logo

Frequency Specific Microcurrent for the Treatment of Diastasis Recti

NCT04060563 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-04-02

Study results available
· View outcomes & findings →

Summary

Determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater.

Conditions

  • Diastasis Recti

Interventions

DEVICE

INSPIRSTAR IS02 MICROCURRENT STIMULATOR

Investigators will use the Inspirstar microcurrent stimulator TENS device. It is an FDA 510k approved portable hand-held device used for the symptomatic relief of chronic pain. It generates low current intensity pulses in the ranges of 20μA to 400μA. For this study, investigators will use a treatment range of 100-300μA. Frequency specific microcurrent therapy (100-300μA microccurrent amps) with Diastasis Recti Repair protocol (8), times 2 treatments for a consistent total of 11 hours 32 minutes.

Sponsors & Collaborators

  • Diana Trang

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-07-07
Completion
2021-07-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04060563 on ClinicalTrials.gov